GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Boston Scientific Corporation (BSX) [hlAlert]

Rating:
Outperform
BSX
up 54.56 %

Boston Scientific Corporation (BSX) rated Outperform with price target $12 by RBC Capital Mkts

Posted on: Friday,  Jul 26, 2013  9:25 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Outperform Boston Scientific Corporation (NYSE: BSX) on 07/26/2013, when the stock price was $10.96.
Since then, Boston Scientific Corporation has gained 54.56% as of 10/28/2015's recent price of $16.94.
If you would have followed this RBC Capital Mkts's recommendation on BSX, you would have gained 54.56% of your investment in 824 days.

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/26/2013 9:25 AM Buy
None
10.96 12.00
as of 12/13/2013
1 Week down  -3.88 %
1 Month down  -4.52 %
3 Months down  -3.80 %
1 YTD up  3.92 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/31/2013 9:25 AM Buy
None
9.23 11.00
7/22/2010 10:25 AM Hold
None
6.07 7.00
10/21/2009 11:25 AM Buy
None
8.45 9.00
2/26/2009 8:25 AM Buy
None
8.18
7/23/2007 11:25 AM Hold
None
14.70 14.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy